null

SMILES CN1CCC(O)(CC1)c1nc(c(o1)-c1ccncc1)-c1ccc(F)cc1

InChI Key InChIKey=OLWWIAFRNOFHTL-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 13 hits for monomerid = 50089126   

TargetProstaglandin G/H synthase 1(Ovis aries (Sheep))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of Prostaglandin G/H synthase 1, COX-1More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetTyrosine-protein kinase ABL1(Mus musculus)
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 8.68E+4nMAssay Description:Inhibition of c-abl kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetMitogen-activated protein kinase 14(Mus musculus (mouse))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 350nMAssay Description:Inhibition of murine p38 alpha MAP kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetMitogen-activated protein kinase 8(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of JNK1 kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 2.27E+4nMAssay Description:Inhibition of c-src kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetDual specificity mitogen-activated protein kinase kinase 6(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of MKK6b kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetMitogen-activated protein kinase 14(Mus musculus (mouse))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 350nMAssay Description:Inhibition of murine phosphorylated His-Mitogen-activated protein kinase p38 alpha.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2V69J2CPubMed
TargetMitogen-activated protein kinase 13(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human p38 delta MAP kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetMitogen-activated protein kinase 1(Mus musculus (Mouse))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ERK2 kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetMitogen-activated protein kinase 9(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 8.09E+3nMAssay Description:Inhibition of JNK2 kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetMitogen-activated protein kinase 11(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 2.41E+3nMAssay Description:Inhibition of human p38 beta MAP kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 797nMAssay Description:Inhibition of EGFR kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed
TargetProtein kinase C alpha type(Bos taurus (bovine))
Novartis Pharma AG

Curated by ChEMBL
LigandPNGBDBM50089126(4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-oxazol-2-yl]...)copy SMILEScopy InChI
Affinity DataIC50: 5.11E+4nMAssay Description:Inhibition of PKCalpha kinaseMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XS5TMTPubMed